ZA83955B - Ergot alkaloids - Google Patents

Ergot alkaloids

Info

Publication number
ZA83955B
ZA83955B ZA83955A ZA83955A ZA83955B ZA 83955 B ZA83955 B ZA 83955B ZA 83955 A ZA83955 A ZA 83955A ZA 83955 A ZA83955 A ZA 83955A ZA 83955 B ZA83955 B ZA 83955B
Authority
ZA
South Africa
Prior art keywords
ergot alkaloids
ergot
alkaloids
Prior art date
Application number
ZA83955A
Other languages
English (en)
Inventor
Rudolf K A Giger
Original Assignee
Sandoz Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ltd filed Critical Sandoz Ltd
Publication of ZA83955B publication Critical patent/ZA83955B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D519/00Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • C07D519/02Ergot alkaloids of the cyclic peptide type

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
ZA83955A 1982-02-12 1983-02-11 Ergot alkaloids ZA83955B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH89382 1982-02-12

Publications (1)

Publication Number Publication Date
ZA83955B true ZA83955B (en) 1984-09-26

Family

ID=4197630

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA83955A ZA83955B (en) 1982-02-12 1983-02-11 Ergot alkaloids

Country Status (6)

Country Link
JP (1) JPS58148888A (de)
BE (1) BE895842A (de)
FR (1) FR2528850B1 (de)
HU (1) HU187003B (de)
SU (1) SU1189351A3 (de)
ZA (1) ZA83955B (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3649599A (en) * 1998-04-16 1999-11-01 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Salivary prolactin test for serotonergic activity

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH505102A (de) * 1967-11-01 1971-03-31 Sandoz Ag Verfahren zur Herstellung neuer Mutterkornpeptidalkaloide
US3891652A (en) * 1973-06-28 1975-06-24 Squibb & Sons Inc Antianginal aryldecahydropyrrolo{8 3,4-f{9 quinolines
CH602765A5 (de) * 1974-09-27 1978-07-31 Sandoz Ag

Also Published As

Publication number Publication date
FR2528850B1 (fr) 1985-07-26
JPS58148888A (ja) 1983-09-05
FR2528850A1 (fr) 1983-12-23
SU1189351A3 (ru) 1985-10-30
HU187003B (en) 1985-10-28
JPH0352473B2 (de) 1991-08-12
BE895842A (fr) 1983-08-08

Similar Documents

Publication Publication Date Title
GB8311973D0 (en) Quinoline derivatives
DE3377796D1 (en) Quinoline derivatives
ZA833008B (en) Ergoline derivatives
GB2125041B (en) Ergot alkaloids
AU553514B2 (en) Vinca alkaloids
PH21234A (en) Ergot alkaloids
PT72785A (en) Ergoline derivatives
GB2115811B (en) Ergot alkaloids
GB2074566B (en) Ergoline derivatives
GB2092570B (en) Ergot alkaloids
ZA812103B (en) Ergoline derivatives
NZ189422A (en) Ergot peptide alkaloids
ZA83955B (en) Ergot alkaloids
GB2094798B (en) Ergot alkaloids
PH20160A (en) Ergoline derivatives
JPS57159783A (en) Manufacture of ergot alkaloids
GB2131674B (en) Ashtray
IE802091L (en) Ergot peptide alkaloids
GB2135307B (en) Ergot derivatives
KR840000329Y1 (en) Ashtray
KR860000957Y1 (en) Ashtray
GB8312447D0 (en) Ergot derivatives
ZA841150B (en) Ergot derivatives
IE822659L (en) Morphinane derivatives
IE820346L (en) Quinoline derivatives